Connect Biopharma Holdings Ltd
CNTB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835268
No open-market purchases or sales by Connect Biopharma Holdings Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $33.1M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Connect Biopharma Holdings Ltd as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q2 2025
- Shares held
- 1.62M
- −822.1K (−33.6%) vs. Q2 2025
- Total value
- $2.45M
- +$46.7K (+1.9%) vs. Q2 2025
- New holders
- 5
- 3 more added
- Sold out
- 6
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $33.1M |
| Q1 2026 | 41 | $32.4M |
| Q4 2025 | 29 | $23.9M |
| Q3 2025 | 16 | $2.45M |
| Q2 2025 | 17 | $2.40M |
| Q1 2025 | 13 | $1.56M |
| Q4 2024 | 14 | $4.37M |
| Q3 2024 | 11 | $4.23M |
| Q2 2024 | 12 | $4.52M |
| Q1 2024 | 12 | $6.87M |
| Q4 2023 | 15 | $8.40M |
| Q3 2023 | 14 | $8.22M |
| Q2 2023 | 16 | $11.7M |
| Q1 2023 | 16 | $10.9M |
| Q4 2022 | 20 | $9.60M |
| Q3 2022 | 25 | $16.4M |
| Q2 2022 | 29 | $13.0M |
| Q1 2022 | 28 | $53.4M |
| Q4 2021 | 29 | $87.4M |
| Q3 2021 | 20 | $467.5M |
| Q2 2021 | 16 | $372.4M |
| Q1 2021 | 26 | $284.6M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Connect Biopharma Holdings Ltd; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 1,267,500 | $1.91M | 1.76% | −554,058−30.4% | Reduced |
| Renaissance Technologies LLC | 158,200 | $238.9K | 0.00% | +14,500+10.1% | Added |
| Marshall Wace, LLP | 58,031 | $85.9K | 0.00% | +58,031 | New |
| Koa Wealth Management, LLC | 49,600 | $74.9K | 0.06% | 00.0% | Unchanged |
| XTX Topco Ltd | 23,724 | $35.1K | 0.00% | −5,138−17.8% | Reduced |
| Geode Capital Management, LLC | 23,320 | $34.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 13,748 | $20.3K | 0.00% | +13,748 | New |
| Monograph Wealth Advisors, LLC | 11,130 | $16.8K | 0.00% | +11,130 | New |
| HRT Financial LP | 10,457 | $15.0K | 0.00% | +10,457 | New |
| Citigroup Inc | 4,214 | $6.24K | 0.00% | +4,214 | New |
| EverSource Wealth Advisors, LLC | 1,582 | $2.39K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 780 | $1.15K | 0.00% | −1,590−67.1% | Reduced |
| UBS Group AG | 201 | $304 | 0.00% | +159+378.6% | Added |
| JPMorgan Chase & Co | 121 | $179 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 100 | $151 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 7 | $11 | 0.00% | +1+16.7% | Added |
| RSM US Wealth Management LLC | 0 | $0 | 0.00% | −160,867−100.0% | Sold out |
| AlphaCore Capital LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −61,992−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −40,400−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |